Skip to main content

NIAMS to Fund GWA Studies for Arthritis, Muscle and Skin Diseases

NEW YORK (GenomeWeb News) – The National Institutes of Health plans to fund genome-wide association studies with around $1 million each year over three years that will advance the understanding of arthritis, musculoskeletal diseases, and skin diseases.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases will offer between two and four projects with up to $200,000 per year for up to two years during 2009, 2010, and 2011, NIH said today.  

The studies will use existing genetic and clinical data, such as that available in the NIH’s database of Genotype and Phenotype or in other similar data sources, and will not require genotyping of samples, or recruitment or clinical characterization of subjects.

Because these studies will not involve use of subjects or genotyping, NIAMS said, these programs may be completed at modest expense and within two years.

The grants under the Genome-Wide Association Analysis of Existing Data Sets for Arthritis and Musculoskeletal and Skin Diseases will provide support for personnel, data storage and computation, travel, and other costs, NIH said.  

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.